Karimi Mobarakeh Mahmood, Nemati Ali, Fazli Ali, Fallahi Amirhossein, Safari Saeid
Department of Trauma and Orthopedic Surgery, Kerman University of Medical Sciences, Shahid Bahonar Hospital, Kerman, IR Iran.
Department of Trauma and Orthopedic Surgery, Shahid Beheshti University of Medical Sciences, Imam Hossein Hospital, Tehran, IR Iran.
Trauma Mon. 2013 Winter;17(4):393-5. doi: 10.5812/traumamon.5095. Epub 2013 Jan 15.
Tennis elbow (TE) is a common myotendinosis. It was first described by Runge in 1873; different modes of treatment are used in management of TE.
This study aimed to report the results of autologous blood injection (ABI) in the treatment of TE.
A prospective case study was performed to evaluate the results of ABI in the management of TE. The level of pain based on Nirschl phase scale (NPS) and a visual analogue scale (VAS) was calculated before and 1, 3 and 6 months after injection; then satisfaction was assessed.
Twenty-nine patients with diagnosed TE were treated by ABI (24% males, 76 % female). The mean age of the patients was 44.1 ± 5.2 years. The level of pain on VAS decreased from 6.46 ± 2.08 to 0.54 ± 0.7 (P=0.001) and on NPS from 6.15 ± 1.48 to 0.54 ± 0.76 (P = 0.001) 6 months after treatment. At the end of the study, 84% of patients expressed a high level of satisfaction.
Given the acceptable outcomes, autologous blood injection can be considered a good treatment option for TE when traditional treatment has fails.
网球肘(TE)是一种常见的肌腱病。它于1873年由伦格首次描述;在网球肘的治疗中采用了不同的治疗方式。
本研究旨在报告自体血注射(ABI)治疗网球肘的结果。
进行一项前瞻性病例研究以评估自体血注射治疗网球肘的效果。在注射前以及注射后1、3和6个月,根据尼氏分期量表(NPS)和视觉模拟量表(VAS)计算疼痛程度;然后评估满意度。
29例确诊为网球肘的患者接受了自体血注射治疗(男性占24%,女性占76%)。患者的平均年龄为44.1±5.2岁。治疗6个月后,视觉模拟量表上的疼痛程度从6.46±2.08降至0.54±0.7(P=0.001),尼氏分期量表上的疼痛程度从6.15±1.48降至0.54±0.76(P=0.001)。在研究结束时,84%的患者表示高度满意。
鉴于可接受的治疗效果,当传统治疗失败时,自体血注射可被视为网球肘的一种良好治疗选择。